|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 March 2001, Vol. 97, No. 6, pp. 1879-1881
BRIEF REPORT
Activation of multiple cryptic donor splice sites by the common
congenital afibrinogenemia mutation, FGA IVS4 + 1
G T
Catia Attanasio,
Philippe de Moerloose,
Stylianos E. Antonarakis,
Michael A. Morris, and
Marguerite Neerman-Arbez
From the Division of Medical Genetics, University
Medical School and University Hospital, Geneva, and the Division of
Angiology and Hemostasis, University Hospital, Geneva, Switzerland.
Our recent studies on the molecular basis of the autosomal
recessive disorder congenital afibrinogenemia showed that the most common mutation is a donor splice mutation in FGA intron 4, IVS4 + 1 G T, accounting for approximately half of disease alleles. The effect of this mutation on messenger RNA (mRNA) splicing, however,
remained unproven. COS-7 cells transfected with a normal plasmid
construct produced 100% mRNA molecules with correct splicing, whereas
cells transfected with a mutant construct produced multiple aberrant
mRNAs, due to utilization of cryptic donor splice sites situated in
exon 4 and intron 4. One particular site situated 4 base pairs (bp)
downstream of the normal site was used in 85% of transcripts causing
afibrinogenemia by a 4-bp insertion-frameshift, leading to premature
alpha-chain truncation. Our results confirm the utility of transfecting
COS-7 cells to study mRNA splice-site mutations and demonstrate that
the common FGA IVS4 variant is a null mutation leading to afibrinogenemia.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Buratti, M. Chivers, J. Kralovicova, M. Romano, M. Baralle, A. R. Krainer, and I. Vorechovsky
Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization
Nucleic Acids Res.,
July 26, 2007;
35(13):
4250 - 4263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Spena, M. L. Tenchini, and E. Buratti
Cryptic splice site usage in exon 7 of the human fibrinogen B{beta}-chain gene is regulated by a naturally silent SF2/ASF binding site within this exon
RNA,
June 1, 2006;
12(6):
948 - 958.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Roca, R. Sachidanandam, and A. R. Krainer
Intrinsic differences between authentic and cryptic 5' splice sites
Nucleic Acids Res.,
November 1, 2003;
31(21):
6321 - 6333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Borensztajn, M.-L. Sobrier, A.-M. Fischer, O. Chafa, S. Amselem, and J. Tapon-Bretaudiere
Factor VII gene intronic mutation in a lethal factor VII deficiency: effects on splice-site selection
Blood,
July 15, 2003;
102(2):
561 - 563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Attanasio, A. David, and M. Neerman-Arbez
Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA)
Blood,
March 1, 2003;
101(5):
1851 - 1856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Spena, S. Duga, R. Asselta, M. Malcovati, F. Peyvandi, and M. L. Tenchini
Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta -chain gene causing activation of cryptic splice sites
Blood,
December 15, 2002;
100(13):
4478 - 4484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Okumura, F. Terasawa, H. Tanaka, M. Hirota, H. Ota, K. Kitano, K. Kiyosawa, and S. T. Lord
Analysis of fibrinogen gamma -chain truncations shows the C-terminus, particularly gamma Ile387, is essential for assembly and secretion of this multichain protein
Blood,
May 15, 2002;
99(10):
3654 - 3660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Asselta, S. Duga, S. Spena, E. Santagostino, F. Peyvandi, G. Piseddu, R. Targhetta, M. Malcovati, P. M. Mannucci, and M. L. Tenchini
Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen Aalpha -chain gene are not associated with the decay of the mutant mRNAs
Blood,
December 15, 2001;
98(13):
3685 - 3692.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|